Screenshot 2025 11 29 165538 National List of Essential Medicines (NLEM)

National List of Essential Medicines (NLEM)

by

The National List of Essential Medicines (NLEM) is a carefully curated list of medicines deemed essential for addressing the healthcare needs of the majority of the population. These medicines are intended to be available at all times, in adequate quantities, in appropriate dosage forms, and at affordable prices. The concept of essential medicines is rooted in public health priorities, aiming to provide equitable access to life-saving and disease-preventing drugs, particularly in resource-constrained settings.

image 6 National List of Essential Medicines (NLEM)

In India, the NLEM is maintained by the Ministry of Health and Family Welfare (MoHFW), and its enforcement and implications are closely tied to the Drugs Price Control Order (DPCO), which regulates the prices of medicines included in the list.

1. Historical Background

The idea of essential medicines emerged globally in the 1970s, with the World Health Organization (WHO) introducing the first Model List of Essential Medicines in 1977. The WHO list serves as a global reference, emphasizing public health relevance, efficacy, safety, and cost-effectiveness.

In India:

  • 1996: India introduced its first National List of Essential Medicines.
  • 2003, 2011, 2015, 2022: The NLEM has been periodically revised to reflect changing healthcare needs, epidemiological trends, and the introduction of newer and more effective medicines.
  • The NLEM 2011 formed the basis for DPCO 2013, as price regulation was applied to medicines included in this list.

2. Objectives of NLEM

The National List of Essential Medicines has several key objectives:

  1. Accessibility: Ensure that essential drugs are available in sufficient quantity at all levels of healthcare.
  2. Affordability: Promote cost-effective pricing and inclusion in government schemes to reduce out-of-pocket expenditure.
  3. Rational Use: Encourage rational prescription and avoid unnecessary or inappropriate medication.
  4. Public Health Prioritization: Focus on medicines that address the most prevalent, high-burden, or life-threatening diseases.
  5. Guideline for Procurement: Serve as a reference for government procurement, hospital formularies, and state drug lists.

3. Criteria for Selection of Medicines in NLEM

Medicines included in the NLEM are selected based on scientific evidence, public health need, and cost-effectiveness. Key criteria include:

  1. Disease Prevalence and Public Health Relevance: Medicines for common and life-threatening conditions such as infections, cardiovascular diseases, diabetes, and respiratory illnesses.
  2. Efficacy and Safety: Drugs must have proven therapeutic efficacy and an acceptable safety profile based on clinical evidence.
  3. Cost-Effectiveness: Preference is given to affordablemedicines that provide maximum health benefit per unit cost.
  4. Suitability for Primary Care: Medicines should be available in dosage forms suitable for all age groups, including children and elderly.
  5. Stability and Storage Requirements: Drugs must be stable under standard storage conditions, considering the Indian climate and infrastructure.
  6. Availability of Alternatives: Essential medicines may have multiple generic options to ensure supply continuity and competitive pricing.

4. Structure and Contents of NLEM

The NLEM categorizes medicines according to therapeutic class, dosage form, and strength. Some broad categories include:

  • Anti-infectives: Antibiotics, antivirals, antifungals, and antiparasitic drugs.
  • Cardiovascular drugs: Anti-hypertensives, anti-anginal agents, anticoagulants.
  • Analgesics and antipyretics: Pain relief and fever management medicines.
  • Gastrointestinal drugs: Antacids, antiemetics, antidiarrheals.
  • Endocrine drugs: Insulin, oral hypoglycemics, thyroid medicines.
  • Respiratory drugs: Bronchodilators, corticosteroids, and antihistamines.
  • Vitamins and minerals: Nutritional supplements for deficiency disorders.
  • Emergency and essential surgical drugs: Anaesthetics, antiseptics, and life-saving injectables.

Each entry specifies the generic name, recommended strength, dosage form, and essential notes for use.

5. Significance of NLEM

  1. Policy Implementation: Forms the basis for government drug procurement, hospital formularies, and state essential drug lists. Guides the implementation of price controls under DPCO 2013.
  2. Public Health Impact: Ensures availability of life-saving medicines at affordable prices, reducing morbidity and mortality. Addresses priority health concerns in India, such as tuberculosis, malaria, HIV/AIDS, cardiovascular diseases, and diabetes.
  3. Economic and Regulatory Importance: Controls drug costs in both public and private sectors. Encourages manufacturers to produce generics of essential medicines, improving market competition and lowering prices.
  4. Rational Use of Medicines: Promotes prescribing based on evidence, safety, and necessity, preventing overuse or misuse of medicines. Supports healthcare education and awareness on essential drugs.

6. NLEM and DPCO 2013 Linkage

  • Price Control: Medicines listed in NLEM are automatically considered scheduled drugs under DPCO 2013.
  • Ceiling Prices: NPPA fixes the maximum retail price (MRP) for these drugs to ensure affordability.
  • Periodic Review: As the NLEM is updated, NPPA revises ceiling prices and includes new drugs to reflect contemporary healthcare needs.

Example:

  • Paracetamol, Amoxicillin, Metformin, and Atenolol are included in NLEM.
  • These drugs have their prices regulated under DPCO 2013 to maintain accessibility and affordability, especially in rural and low-income populations.

7. Revisions and Updates

  • NLEM is not static; it undergoes revisions to account for:
    1. Emerging diseases (e.g., viral infections, pandemics)
    2. New therapeutic advances
    3. Safety and efficacy data from clinical studies
    4. Economic considerations and cost-effectiveness analysis

Example:

  • NLEM 2011 had 348 drugs.
  • NLEM 2022 expanded to 384 drugs, adding newer essential medicines and revising obsolete entries.

8. Global Context and Alignment

  • India’s NLEM is aligned with WHO’s Model List of Essential Medicines but tailored to national disease burden, epidemiology, and socio-economic conditions.
  • This ensures global best practices while addressing local public health priorities.

9. Importance in Healthcare Delivery

  1. Equitable Access: Guarantees availability of essential drugs even in remote areas.
  2. Cost Containment: Reduces out-of-pocket expenditure for patients.
  3. Rational Prescription: Guides clinicians in evidence-based drug selection.
  4. Supply Chain Efficiency: Standardizes drug procurement, reducing shortages and stockouts.

Conclusion

The National List of Essential Medicines (NLEM) is a strategic instrument for India’s public health system, ensuring that medicines of proven efficacy, safety, and cost-effectiveness are available to the entire population. It serves as the foundation for price regulation under DPCO 2013, supports rational drug use, and provides a roadmap for government procurement and healthcare delivery. Periodic revisions ensure that NLEM remains relevant, contemporary, and aligned with India’s evolving healthcare priorities.

Leave a Comment